A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma
Mayo Clinic
Mayo Clinic
Institute of Hematology & Blood Diseases Hospital, China
UNC Lineberger Comprehensive Cancer Center
Barbara Ann Karmanos Cancer Institute
UNC Lineberger Comprehensive Cancer Center
Memorial Sloan Kettering Cancer Center